ANOMALY WEALTHMutual Fund Intelligence HoldingsSep 2026 Trade Intelligence ↗
FUNCTION CODESType a code in the search bar and press Enter
TOPWhat funds are buyingBUYMost bought stocks (₹)SELLMost sold stocks (₹)SCRNStock screenerSECTSectorsINSOwnership & liquidity insightsFLOWMoney flowsHEATFlow heatmapNFONew fund offersSIPSIP trendsFIIFII & DII dailyCATCategoriesFUNDFund explorerCMPCompare fundsAMCFund housesSHRFund-house market shareXRAYPortfolio X-rayMONMonthly reportDIGWhat changedRESResearch: what held upDATAData status
KEYBOARDAnywhere outside a text box

/Command bar

?This help

ghHome

gmMonthly report

gaWhat funds are buying

gsStocks

gfFunds

glMoney flows

gcCategories

goFund houses

gxPortfolio X-ray

grResearch

Economic portfolio

Nippon India Nifty Pharma ETF

NIPPON Nippon India Mutual Fund Feb 2022 — Sep 2026 55 months

Data periodFund holdingsSep 2026NSE prices23 Oct 2026Data status →

Indian listed equity disclosed₹1,736 CrAt NSE closes, Sep 2026
Companies held2020 with an NSE price
Top 10 holdings78.2%Of the equity shown here
Largest holding19.5%Sun Pharmaceutical Industries Limited
12-month turnover6.4%Estimated from 12 monthly disclosures · compare

Days to sell half: 2.3 — selling half of every holding at 20% of each stock’s usual daily NSE trading, the time to get through 90% of the portfolio (Sep 2026). Quick to unwind on normal volumes. Small-cap comparison →

Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.

How concentrated it has been

55 priced months, Feb 2022 to Sep 2026 · at each month’s NSE closes

Top 10 holdings, share of equity

78.2% now, 78.0% in Sep 2025 · highest 83.0%, lowest 78.0%

Companies held

20 now, 20 in Sep 2025 · largest single holding 19.5% of equity

How it trades: no clear lean toward recent winners or losers (score -0.04 over 47 months; −1 always buys the biggest fallers, +1 the biggest risers, 0 no pattern). Value and contra funds average −0.10, other active funds about 0. A description of behaviour, not of results. How this was tested →

Sector mix

Share of the equity shown · NSE industry

Funds most like this one

Overlap of disclosed equity · the smaller share of each company both hold, added up

  1. ICICI Prudential Nifty Pharma Index FundICICI Prudential · 20 shared100.0%
  2. ICICI Prudential Nifty Healthcare ETFICICI Prudential · 16 shared81.1%
  3. DSP Nifty Healthcare ETFDSP · 16 shared81.1%
  4. Axis NIFTY Healthcare ETFAxis · 16 shared81.1%
  5. DSP Nifty Healthcare Index FundDSP · 16 shared81.1%
  6. ADITYA BIRLA SUN LIFE NIFTY HEALTHCARE ETFAditya Birla Sun Life · 16 shared81.1%
  7. EODWHFEdelweiss · 17 shared77.4%
  8. Mirae Asset Nifty 500 Healthcare ETFMirae Asset · 20 shared69.0%

Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.

What changed in Sep 2026

This portfolio’s consecutive disclosures · evidenced adjustments applied

New positions 0 Companies added
Complete exits 0 Companies sold out
Increases 19 More shares than last month
Reductions 1 Fewer shares than last month

Share quantities, not market values or cash flows.

Holdings by value

Sep 2026 · largest 100 · share of the equity shown

Download all (CSV)
CompanySectorSizeShare of equityValueShares heldHeld since
Sun Pharmaceutical Industries Limited Healthcare Large Cap 19.51% 339 Cr 0.19 Cr by Feb 2022 (55 mo+)
Divi's Laboratories Limited Healthcare Large Cap 11.98% 208 Cr 0.02 Cr by Feb 2022 (55 mo+)
Laurus Labs Limited Healthcare Mid Cap 7.82% 136 Cr 0.07 Cr by Feb 2022 (55 mo+)
Cipla Limited Healthcare Large Cap 7.68% 133 Cr 0.10 Cr by Feb 2022 (55 mo+)
Dr. Reddy's Laboratories Limited Healthcare Large Cap 7.63% 132 Cr 0.11 Cr by Feb 2022 (55 mo+)
Torrent Pharmaceuticals Limited Healthcare Large Cap 7.16% 124 Cr 0.03 Cr by Feb 2022 (55 mo+)
Lupin Limited Healthcare Mid Cap 5.00% 86.83 Cr 0.04 Cr by Feb 2022 (55 mo+)
Aurobindo Pharma Limited Healthcare Mid Cap 4.69% 81.36 Cr 0.05 Cr by Feb 2022 (55 mo+)
Glenmark Pharmaceuticals Limited Healthcare Mid Cap 3.57% 61.89 Cr 0.03 Cr by Feb 2022 (55 mo+)
Alkem Laboratories Limited Healthcare Mid Cap 3.16% 54.82 Cr 0.01 Cr by Feb 2022 (55 mo+)
Zydus Lifesciences Limited Healthcare Mid Cap 2.92% 50.70 Cr 0.04 Cr by Feb 2022 (55 mo+)
Mankind Pharma Limited Healthcare Mid Cap 2.88% 49.96 Cr 0.02 Cr Mar 2024 (30 mo)
IPCA Laboratories Limited Healthcare Mid Cap 2.72% 47.14 Cr 0.02 Cr by Feb 2022 (55 mo+)
Biocon Limited Healthcare Mid Cap 2.62% 45.44 Cr 0.12 Cr by Feb 2022 (55 mo+)
Gland Pharma Limited Healthcare Small Cap 2.34% 40.69 Cr 0.01 Cr by Feb 2022 (55 mo+)
Sai Life Sciences Limited Healthcare Small Cap 2.14% 37.13 Cr 0.02 Cr Jul 2026 (3 mo)
Wockhardt Limited Healthcare Small Cap 1.77% 30.78 Cr 0.01 Cr Sep 2025 (13 mo)
Ajanta Pharma Limited Healthcare Small Cap 1.67% 29.06 Cr 80,268 Sep 2024 (25 mo)
Abbott India Limited Healthcare Mid Cap 1.43% 24.89 Cr 9,176 by Feb 2022 (55 mo+)
Piramal Pharma Limited Healthcare Small Cap 1.30% 22.59 Cr 0.11 Cr Sep 2025 (13 mo)

Half of its current holdings have been held for 55 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.

Recent position changes

Latest 100 company-month records · evidenced adjustments applied

CompanyMonthActivityAdjusted change
Sun Pharmaceutical Industries Limited Sep 2026 ▲ Increasing +23,565
Dr. Reddy's Laboratories Limited Sep 2026 ▲ Increasing +14,091
Biocon Limited Sep 2026 ▼ Reducing -13,184
Cipla Limited Sep 2026 ▲ Increasing +12,685
Piramal Pharma Limited Sep 2026 ▲ Increasing +12,478
Laurus Labs Limited Sep 2026 ▲ Increasing +9,367
Ajanta Pharma Limited Sep 2026 ▲ Increasing +7,039
Lupin Limited Sep 2026 ▲ Increasing +5,525
Aurobindo Pharma Limited Sep 2026 ▲ Increasing +5,426
Alkem Laboratories Limited Sep 2026 ▲ Increasing +4,432
Torrent Pharmaceuticals Limited Sep 2026 ▲ Increasing +4,105
Sai Life Sciences Limited Sep 2026 ▲ Increasing +3,671
Glenmark Pharmaceuticals Limited Sep 2026 ▲ Increasing +3,356
IPCA Laboratories Limited Sep 2026 ▲ Increasing +3,133
Divi's Laboratories Limited Sep 2026 ▲ Increasing +2,839
Mankind Pharma Limited Sep 2026 ▲ Increasing +2,731
Wockhardt Limited Sep 2026 ▲ Increasing +1,890
Gland Pharma Limited Sep 2026 ▲ Increasing +1,810
Zydus Lifesciences Limited Sep 2026 ▲ Increasing +1,378
Abbott India Limited Sep 2026 ▲ Increasing +121
Sun Pharmaceutical Industries Limited Aug 2026 ▲ Increasing +31,424
Biocon Limited Aug 2026 ▲ Increasing +21,177
Piramal Pharma Limited Aug 2026 ▲ Increasing +18,485
Dr. Reddy's Laboratories Limited Aug 2026 ▲ Increasing +18,084
Cipla Limited Aug 2026 ▲ Increasing +16,687
Laurus Labs Limited Aug 2026 ▲ Increasing +11,543
Aurobindo Pharma Limited Aug 2026 ▲ Increasing +8,196
Zydus Lifesciences Limited Aug 2026 ▲ Increasing +7,444
Lupin Limited Aug 2026 ▲ Increasing +7,190
Glenmark Pharmaceuticals Limited Aug 2026 ▲ Increasing +4,458
Torrent Pharmaceuticals Limited Aug 2026 ▲ Increasing +4,371
IPCA Laboratories Limited Aug 2026 ▲ Increasing +4,142
Sai Life Sciences Limited Aug 2026 ▲ Increasing +4,129
Divi's Laboratories Limited Aug 2026 ▲ Increasing +3,766
Mankind Pharma Limited Aug 2026 ▲ Increasing +3,329
Wockhardt Limited Aug 2026 ▲ Increasing +2,445
Gland Pharma Limited Aug 2026 ▲ Increasing +2,345
Alkem Laboratories Limited Aug 2026 ▲ Increasing +1,745
Ajanta Pharma Limited Aug 2026 ▲ Increasing +1,314
Abbott India Limited Aug 2026 ▲ Increasing +149
Sai Life Sciences Limited Jul 2026 ▲ New position +0.02 Cr
J.B. Chemicals & Pharmaceuticals Lt Jul 2026 ▼ Complete exit -0.01 Cr
Torrent Pharmaceuticals Limited Jul 2026 ▲ Increasing +66,729
Sun Pharmaceutical Industries Limited Jul 2026 ▼ Reducing -46,248
Biocon Limited Jul 2026 ▼ Reducing -31,131
Piramal Pharma Limited Jul 2026 ▼ Reducing -27,185
Dr. Reddy's Laboratories Limited Jul 2026 ▼ Reducing -26,612
Cipla Limited Jul 2026 ▼ Reducing -24,573
Laurus Labs Limited Jul 2026 ▼ Reducing -16,974
Aurobindo Pharma Limited Jul 2026 ▼ Reducing -12,094
Zydus Lifesciences Limited Jul 2026 ▼ Reducing -10,945
Lupin Limited Jul 2026 ▼ Reducing -10,594
Glenmark Pharmaceuticals Limited Jul 2026 ▼ Reducing -6,576
IPCA Laboratories Limited Jul 2026 ▼ Reducing -6,095
Divi's Laboratories Limited Jul 2026 ▼ Reducing -5,544
Mankind Pharma Limited Jul 2026 ▼ Reducing -4,930
Wockhardt Limited Jul 2026 ▼ Reducing -3,593
Gland Pharma Limited Jul 2026 ▼ Reducing -3,464
Alkem Laboratories Limited Jul 2026 ▼ Reducing -2,544
Ajanta Pharma Limited Jul 2026 ▼ Reducing -1,898
Abbott India Limited Jul 2026 ▼ Reducing -222
Sun Pharmaceutical Industries Limited Jun 2026 ▼ Reducing -13,810
Biocon Limited Jun 2026 ▼ Reducing -9,827
Aurobindo Pharma Limited Jun 2026 ▼ Reducing -8,462
Dr. Reddy's Laboratories Limited Jun 2026 ▼ Reducing -7,682
Cipla Limited Jun 2026 ▼ Reducing -7,240
Laurus Labs Limited Jun 2026 ▼ Reducing -5,124
Piramal Pharma Limited Jun 2026 ▼ Reducing -4,077
Zydus Lifesciences Limited Jun 2026 ▼ Reducing -3,235
Lupin Limited Jun 2026 ▼ Reducing -2,656
Glenmark Pharmaceuticals Limited Jun 2026 ▼ Reducing -1,976
IPCA Laboratories Limited Jun 2026 ▼ Reducing -1,769
Divi's Laboratories Limited Jun 2026 ▼ Reducing -1,654
Mankind Pharma Limited Jun 2026 ▼ Reducing -1,367
Wockhardt Limited Jun 2026 ▼ Reducing -1,137
J.B. Chemicals & Pharmaceuticals Lt Jun 2026 ▼ Reducing -1,078
Gland Pharma Limited Jun 2026 ▼ Reducing -874
Alkem Laboratories Limited Jun 2026 ▼ Reducing -774
Torrent Pharmaceuticals Limited Jun 2026 ▼ Reducing -772
Ajanta Pharma Limited Jun 2026 ▼ Reducing -565
Abbott India Limited Jun 2026 ▼ Reducing -66
Sun Pharmaceutical Industries Limited May 2026 ▲ Increasing +0.02 Cr
Biocon Limited May 2026 ▲ Increasing +0.01 Cr
Piramal Pharma Limited May 2026 ▲ Increasing +0.01 Cr
Dr. Reddy's Laboratories Limited May 2026 ▲ Increasing +0.01 Cr
Cipla Limited May 2026 ▲ Increasing +95,210
Laurus Labs Limited May 2026 ▲ Increasing +65,926
Aurobindo Pharma Limited May 2026 ▲ Increasing +47,342
Zydus Lifesciences Limited May 2026 ▲ Increasing +42,311
Lupin Limited May 2026 ▲ Increasing +40,994
Glenmark Pharmaceuticals Limited May 2026 ▲ Increasing +25,440
IPCA Laboratories Limited May 2026 ▲ Increasing +23,606
Divi's Laboratories Limited May 2026 ▲ Increasing +21,473
Mankind Pharma Limited May 2026 ▲ Increasing +19,129
Torrent Pharmaceuticals Limited May 2026 ▲ Increasing +17,734
Wockhardt Limited May 2026 ▲ Increasing +14,108
J.B. Chemicals & Pharmaceuticals Lt May 2026 ▲ Increasing +13,802
Gland Pharma Limited May 2026 ▲ Increasing +13,424
Alkem Laboratories Limited May 2026 ▲ Increasing +10,005
Ajanta Pharma Limited May 2026 ▲ Increasing +7,105

Changes compare consecutive month-end disclosures for this portfolio only.